375 related articles for article (PubMed ID: 9748419)
21. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
22. Interconversion of cortisol and cortisone by 11beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta.
Sun K; Adamson SL; Yang K; Challis JR
Placenta; 1999 Jan; 20(1):13-9. PubMed ID: 9950140
[TBL] [Abstract][Full Text] [Related]
23. Physiologic roles of 11beta-hydroxysteroid dehydrogenase type 2 in kidney.
Isomura Y; Mune T; Morita H; Suwa T; Takada N; Yamamoto Y; Takeda J
Metabolism; 2006 Oct; 55(10):1352-7. PubMed ID: 16979406
[TBL] [Abstract][Full Text] [Related]
24. Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.
Fuster D; Escher G; Vogt B; Ackermann D; Dick B; Frey BM; Frey FJ
Endocrinology; 1998 Sep; 139(9):3849-54. PubMed ID: 9724039
[TBL] [Abstract][Full Text] [Related]
25. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S
Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.
Andrew R; Smith K; Jones GC; Walker BR
J Clin Endocrinol Metab; 2002 Jan; 87(1):277-85. PubMed ID: 11788660
[TBL] [Abstract][Full Text] [Related]
27. 11Beta-hydroxysteroid dehydrogenase bioactivity is increased in the colon but not kidneys of rats given supplementary thyroxine.
Ruszymah BH; Zaiton Z; Aminuddin S; Khalid BA
Exp Clin Endocrinol Diabetes; 2001; 109(4):227-30. PubMed ID: 11453035
[TBL] [Abstract][Full Text] [Related]
28. Ovarian modulators of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity in follicular fluid from gonadotrophin-stimulated assisted conception cycles.
Thurston LM; Norgate DP; Jonas KC; Chandras C; Kloosterboer HJ; Cooke BA; Michael AE
Reproduction; 2002 Dec; 124(6):801-12. PubMed ID: 12530918
[TBL] [Abstract][Full Text] [Related]
29. In vivo characterization of 11beta-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint.
Ajilore OA; Sapolsky RM
Neuroendocrinology; 1999 Feb; 69(2):138-44. PubMed ID: 9986927
[TBL] [Abstract][Full Text] [Related]
30. Implication of cortisol and 11beta-hydroxysteroid dehydrogenase enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts.
Sunak N; Green DF; Abeydeera LR; Thurston LM; Michael AE
Reproduction; 2007 Jun; 133(6):1149-58. PubMed ID: 17636169
[TBL] [Abstract][Full Text] [Related]
31. 11beta-Hydroxysteroid dehydrogenase expression and activities in bovine granulosa cells and corpora lutea implicate corticosteroids in bovine ovarian physiology.
Thurston LM; Abayasekara DR; Michael AE
J Endocrinol; 2007 May; 193(2):299-310. PubMed ID: 17470521
[TBL] [Abstract][Full Text] [Related]
32. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
Patel FA; Sun K; Challis JR
J Clin Endocrinol Metab; 1999 Feb; 84(2):395-400. PubMed ID: 10022390
[TBL] [Abstract][Full Text] [Related]
33. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.
Walker BR; Connacher AA; Webb DJ; Edwards CR
Clin Sci (Lond); 1992 Aug; 83(2):171-8. PubMed ID: 1327632
[TBL] [Abstract][Full Text] [Related]
35. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
Draper N; Stewart PM
J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
Alberts P; Engblom L; Edling N; Forsgren M; Klingström G; Larsson C; Rönquist-Nii Y; Ohman B; Abrahmsén L
Diabetologia; 2002 Nov; 45(11):1528-32. PubMed ID: 12436336
[TBL] [Abstract][Full Text] [Related]
37. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
Quinkler M; Meyer B; Oelkers W; Diederich S
J Clin Endocrinol Metab; 2003 Aug; 88(8):3767-72. PubMed ID: 12915667
[TBL] [Abstract][Full Text] [Related]
38. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.
Stewart PM; Wallace AM; Atherden SM; Shearing CH; Edwards CR
Clin Sci (Lond); 1990 Jan; 78(1):49-54. PubMed ID: 2153495
[TBL] [Abstract][Full Text] [Related]
39. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo.
Best R; Walker BR
Clin Endocrinol (Oxf); 1997 Aug; 47(2):231-6. PubMed ID: 9302399
[TBL] [Abstract][Full Text] [Related]
40. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
